Lanean...
Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells
Pancreatic cancer is characterized by mutated signaling pathways and a high incidence of drug resistance. Comprehensive, large-scale proteomic analysis can provide a system-wide view of signaling networks, assist in understanding drug mechanisms of action and interactions, and serve as a useful tool...
Gorde:
| Argitaratua izan da: | Front Pharmacol |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Frontiers Media S.A.
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5827530/ https://ncbi.nlm.nih.gov/pubmed/29520231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.00084 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|